Ekso Bionics Holdings, Inc.

Company Details:

Company Symbol: EKSO
Sector: Healthcare & Medical Devices
Company Rating:
URL: http://eksobionics.com/

Related Research

  • 03/08/17 Update EKSO ($3.23, Buy; $7.00 PT): 4Q:16 Revenue Beat Preannouncement, Solid Medical and Industrial Sales - Maintain Buy and Reducing Price Target to $7.00.
  • 03/08/17 Morning Note B. Riley AM Note: AOSL, AUXO (initiation), CVU, DKS, EKSO, LGF.A, NTRI, NVDA, NVTR, OOMA, RLH, SWKS, TRUE
  • 01/06/17 Update Industry Update - MedTech: What Medical Technology Investors Should Know as the Healthcare Sector Descends on San Francisco on January 9-12, 2017
  • 12/08/16 Update EKSO ($4.77, Buy; $8.00 PT): Highlights from EKSO’s Analyst Day; PA-based Rehab Center Reports 5-Year IRR of 53% per EKSO GT; Industrial Segment Gaining Traction; Reiterate Buy and $8.00 PT
  • 12/08/16 Morning Note B. Riley AM Note: AMC, EKSO, EMKR, IL, ON, TRUE
  • 11/10/16 Morning Note B. Riley AM Note: ADI, APPS, ARTX, COTY, CROX, CTS (initiation), EKSO, EXAR, FC, GSM, HCHC, IDSY, IPAR, ITI, JCP, MPAA (upgrade), MRVL, NLST, NVTR, PFSW, RELY, SPA, TUBE, WYY; Focus List Update
  • 11/10/16 Update EKSO ($4.30, Buy; $8.00 PT): Revenue Beat as Industrial Segment Tops Our Estimate - Maintain Buy and $8.00 Price Target
  • 09/16/16 Initiation of Coverage EKSO ($3.74, Buy; $8.00 PT): FDA 510(k) Clearance Should Accelerate Medical Segment Growth; Initiating at Buy with a $8.00 PT
  • 09/16/16 Morning Note B. Riley AM Note: AMAT, CFMS (initiating), EKSO (initiating), FTD (downgrade), NVRO (initiating), NVTR (initiating), OXM, P, PFSW, RELY, SQNS, TLYS; Footwear (CROX, DECK, RCKY, VFC, WEYS, WWW)